Familial Risk Assessment in Colorectal Cancer

Familial risk assessment in colorectal cancer evaluates how hereditary and shared environmental factors influence individual susceptibility to colorectal malignancies. A positive family history, particularly among first-degree relatives, doubles to quadruples lifetime risk compared with the general population. High-penetrance syndromes such as Lynch syndrome and familial adenomatous polyposis account for a minority of cases but drive early-onset disease and necessitate intensive surveillance. In families without defined monogenic mutations, risk stratification relies on the number of affected relatives, age at diagnosis, polyp histology and emerging polygenic risk scores. Integrating these parameters into predictive algorithms informs personalised screening schedules, typically commencing at age 40 or ten years before the youngest diagnosis in the pedigree. Cascade testing enables identification of at-risk kin, while tailored endoscopic and non-invasive strategies aim to detect advanced neoplasia at a curable stage. Globally, standardised approaches to family history collection and risk communication enhance uptake of preventive measures, reduce health-care disparities and optimise resource allocation in population-based screening programmes.

Research from Nature Portfolio

A large meta-analysis of Middle Eastern and North African cohorts assessed the impact of familial cancer history on colorectal cancer risk. Pooled data from numerous case–control studies revealed that individuals with a first-degree relative affected by colorectal cancer had more than a twofold increased odds of developing the disease, while a family history of any cancer conferred a 1.8-fold elevation. These findings underscore the universal relevance of systematic family history recording and early screening in regions with variable health-care infrastructure. The analysis highlights the need for regional adaptation of clinical guidelines and the importance of coordinated efforts to promote timely colonoscopic evaluation among high-risk families.

Familial Risk Assessment in Colorectal Cancer publication trend

The graph below shows the total number of articles in familial risk assessment in colorectal cancer across all publications each year (not limited to Nature Index journals).

Technical terms

First-degree relative: A parent, sibling or child of an individual, reflecting the closest genetic relationship.

Standardised incidence ratio: The ratio of observed to expected cancer cases in a study population, adjusted for age and sex.

Polygenic risk score: A composite measure of inherited risk derived from the cumulative effect of multiple common genetic variants.

Lynch syndrome: A hereditary condition caused by germline mutations in DNA mismatch repair genes, predisposing to early-onset colorectal and other cancers.

Cascade testing: Sequential genetic evaluation of relatives following identification of a pathogenic variant in a proband, enabling targeted surveillance.

References

1. Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study). PLOS Medicine (2023).
2. Family history of cancer as a potential risk factor for colorectal cancer in EMRO countries: a systematic review and meta-analysis. Scientific Reports (2023).
3. Risk of colorectal cancer in first degree relatives of patients with colorectal polyps: nationwide case-control study in Sweden. The BMJ (2021).
4. Risk of Colorectal Cancer Associated With Frequency of Colorectal Polyp Diagnosis in Relatives. Gastroenterology (2025).